Prospettive Sociali e Sanitarie

EDITORIALS:
Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes
Mark Weiser, Jim van Os, and Michael Davidson 203-205
Studying suicide from the life course perspective: implications for prevention
D. Gunnell and G. Lewis 206-208
REVIEW ARTICLES:
Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and
neuroimaging studies
G. Dom, B. Sabbe, W. Hulstijn, and W. van den Brink 209-220
PAPERS:
Laterality phenotypes in patients with schizophrenia, their siblings and controls: associations with clinical and
cognitive variables
Milan Dragovic, Geoff Hammond, Johanna C. Badcock, and Assen Jablensky 221-228
Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study
Sumant Khanna, Eduard Vieta, Benjamin Lyons, Fred Grossman, Mariëlle Eerdekens, and Michelle Kramer 229-234
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: Double-blind, randomised, comparative 12-week
trial
Eduard Vieta, Michel Bourin, Raymond Sanchez, Ronald Marcus, Elyse Stock, Robert McQuade, William Carson,
Neveen Abou-Gharbia, Rene Swanink, Taro Iwamoto on behalf of the Aripiprazole Study Group 235-242
Polypharmacy and excessive dosing: psychiatrists’ perceptions of antipsychotic drug prescription
Hiroto Ito, Asuka Koyama, and Teruhiko Higuchi 243-247
Schizophrenia practice guidelines: international survey and comparison
Wolfgang Gaebel, Stefan Weinmann, Norman Sartorius, Wolfgang Rutz, and John S. McIntyre 248-255
Patient-rated mental health needs and quality of life improvement
Mike Slade, Morven Leese, Sharon Cahill, Graham Thornicroft, and Elizabeth Kuipers 256-261
Psychiatric telephone interview with parents for screening of childhood autism – tics, attention-deficit hyperactivity
disorder and other comorbidities (A–TAC): Preliminary reliability and validity
Sara Lina Hansson, Annika Svanström Röjvall, Maria Rastam, Carina Gillberg, Christopher Gillberg, and Henrik
Anckarsäter 262-267
Early experiences and their relationship to maternal eating disorder symptoms, both lifetime and during pregnancy
R. Senior, J. Barnes, J. R. Emberson, J. Golding on behalf of the ALSPAC Study Team 268-273
General practitioners and schizophrenia: results from a Swiss survey
Andor E. Simon, Christoph Lauber, Katja Ludewig, Hellmuth Braun-Scharm, Daniel S. Umbricht for the Swiss Early
Psychosis Project 274-281
SHORT REPORTS:
Fronto-parietal activation in attention-deficit hyperactivity disorder, combined type: functional magnetic resonance
imaging study
T. Silk, A. Vance, N. Rinehart, G. Egan, M. O’Boyle, J. L. Bradshaw, and R. Cunnington 282-283
Cognitive performance in presumed obligate carriers for psychosis
Timothea Toulopoulou, Francesca Mapua-Filbey, Seema Quraishi, Eugenia Kravariti, Robin G. Morris, Colm
McDonald, Muriel Walshe, Elvira Bramon, and Robin M. Murray 284-285
Longitudinal follow-up in acute and transient psychotic disorders and schizophrenia
Frank Pillmann and Andreas Marneros 286-287
Correspondence:
Organic brain dysfunction in late-onset depression A. B. Kaimal and U.V. Nair 288